X0704 D LIVE 0001469231 Slate Pharmaceuticals, Inc. 318 BLACKWELL STREET SUITE 240 DURHAM NC NORTH CAROLINA 27701 919.682.8800 DELAWARE None None Corporation true 2007 Robert Stanley Whitehead c/o Slate Pharmaceuticals, Inc. 318 Blackwell Street, Suite 240 Durham NC NORTH CAROLINA 27701 Executive Officer Director Douglas Eckert c/o Slate Pharmaceuticals, Inc. 318 Blackwell Street, Suite 240 Durham NC NORTH CAROLINA 27701 Director Michael Ford c/o Slate Pharmaceuticals, Inc. 318 Blackwell Street, Suite 240 Durham NC NORTH CAROLINA 27701 Director William Robert Dahl c/o Slate Pharmaceuticals, Inc. 318 Blackwell Street, Suite 240 Durham NC NORTH CAROLINA 27701 Director Trygve Mikkelsen c/o Slate Pharmaceuticals, Inc. 318 Blackwell Street, Suite 240 Durham NC NORTH CAROLINA 27701 Director Richard DeSchutter c/o Slate Pharmaceuticals, Inc. 318 Blackwell Street, Suite 240 Durham NC NORTH CAROLINA 27701 Director Anthony Wild c/o Slate Pharmaceuticals, Inc. 318 Blackwell Street, Suite 240 Durham NC NORTH CAROLINA 27701 Director Pharmaceuticals Decline to Disclose 06 false 2010-09-13 false true true true false 1 N/A None None None N/A N/A N/A NC NORTH CAROLINA 27701 AL ALABAMA AZ ARIZONA CT CONNECTICUT IL ILLINOIS KY KENTUCKY MA MASSACHUSETTS NH NEW HAMPSHIRE NY NEW YORK NC NORTH CAROLINA OH OHIO TX TEXAS false 2000000 1990000 10000 false 40 0 0 N/A 300000 true The $300,000 represents proceeds that may be applied to the salary of Robert S. Whitehead, President of Slate Pharmaceuticals, Inc., as part of the use of proceeds for working capital. false Slate Pharmaceuticals, Inc. /s/ Taylor Caldwell Taylor Caldwell Director of Finance 2010-09-23